Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil caused a severe rash in a patient, which improved after stopping the drug.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Early recognition and management of connective tissue diseases like lupus are crucial in young patients.

The document discusses a condition causing hair loss after surgery and a type of rosacea affecting the nose, with treatments including surgery and laser therapy.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

A woman's hair loss led to discovering she had lupus.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Dermoscopy helps diagnose different scalp conditions by showing unique signs for each disorder.

Mnemonics help improve memory in dermatology by up to 50%.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Different types of skin fibroblasts have unique roles in skin health and disease.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Glucocorticoid treatment in lupus can cause oral lesions, which need early diagnosis and comprehensive care.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Mesenchymal stem cells show promise for effective skin repair and regeneration.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.

Patients with skin of color are more likely to use supplements for hair loss than Caucasian patients, but the effectiveness of these supplements is uncertain and they can be expensive.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Iron deficiency is not more common in women with hair loss, and neurogenic rosacea may need different treatment.